Multicentric Ipilimumab Experience in Turkish Patients with Metastatic Melanoma: MIPI-TURK at 3 years

dc.contributor.authorSevinc, A.
dc.contributor.authorTurna, H.
dc.contributor.authorOzdogan, M.
dc.contributor.authorBuyukberber, S.
dc.contributor.authorDemir, G.
dc.contributor.authorGokmen, E.
dc.contributor.authorMandel, N. M.
dc.contributor.authorPaydas, S.
dc.contributor.authorAkbulut, H.
dc.contributor.authorCelik, I.
dc.date.accessioned2019-10-27T21:51:54Z
dc.date.available2019-10-27T21:51:54Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.identifier.endpage69en_US
dc.identifier.issn1610-0379
dc.identifier.startpage68en_US
dc.identifier.urihttps://hdl.handle.net/11454/47374
dc.identifier.volume11en_US
dc.identifier.wosWOS:000323227600207en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofJournal Der Deutschen Dermatologischen Gesellschaften_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleMulticentric Ipilimumab Experience in Turkish Patients with Metastatic Melanoma: MIPI-TURK at 3 yearsen_US
dc.typeConference Objecten_US

Dosyalar